Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1972 Dec;26(6):444–452. doi: 10.1038/bjc.1972.61

Iron Metabolism in Hodgkin's Disease

M R Beamish, P Ashley Jones, D Trevett, I Howell Evans, A Jacobs
PMCID: PMC2008667  PMID: 4567182

Abstract

An evaluation of iron metabolism has been carried out in 23 untreated patients with Hodgkin's disease and 6 patients with other lymphomata. The reduction in red cell life span is related to the stage of the disease. There is an almost universal impairment of iron release from the reticuloendothelial system with a consequent sideropenia and failure of iron delivery to the bone marrow for erythropoiesis. This defect is found in all stages of the disease and is not related to systemic symptoms.

Full text

PDF
444

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beamish M. R., Davies A. G., Eakins J. D., Jacobs A., Trevett D. The measurement of reticuloendothelial iron release using iron-dextran. Br J Haematol. 1971 Dec;21(6):617–622. doi: 10.1111/j.1365-2141.1971.tb02724.x. [DOI] [PubMed] [Google Scholar]
  2. CLINE M. J., BERLIN N. I. Anemia in Hodgkin's disease. Cancer. 1963 Apr;16:526–532. doi: 10.1002/1097-0142(196304)16:4<526::aid-cncr2820160415>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  3. Cavill I. The preparation of 59 Fe-labelled transferrin for ferrokinetic studies. J Clin Pathol. 1971 Jul;24(5):472–474. doi: 10.1136/jcp.24.5.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eakins J. D., Brown D. A. An improved method for the simultaneous determination of iron-55 and iron-59 in blood by liquid scintillation counting. Int J Appl Radiat Isot. 1966 Jul;17(7):391–397. doi: 10.1016/0020-708x(66)90065-2. [DOI] [PubMed] [Google Scholar]
  5. FREIREICH E. J., MILLER A., EMERSON C. P., ROSS J. F. The effect of inflammation on the utilization of erythrocyte and transferrin bound radioiron for red cell production. Blood. 1957 Nov;12(11):972–983. [PubMed] [Google Scholar]
  6. GIANNOPOULOS P. P., BERGSAGEL D. E. The mechanism of the anemia associated with Hodgkin's disease. Blood. 1959 Jul;14(7):856–869. [PubMed] [Google Scholar]
  7. HAURANI F. I., YOUNG K., TOCANTINS L. M. Reutilization of iron in anemia complicating malignant neoplasma. Blood. 1963 Jul;22:73–81. [PubMed] [Google Scholar]
  8. HOFFBRAND B. I. HAEMOLYTIC ANAEMIA IN HODGKIN'S DISEASE ASSOCIATED WITH IMMUNOGLOBULIN DEFICIENCIES. Br J Cancer. 1964 Mar;18:98–101. doi: 10.1038/bjc.1964.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Henderson P. A., Hillman R. S. Characteristics of iron dextran utilization in man. Blood. 1969 Sep;34(3):357–375. [PubMed] [Google Scholar]
  10. LEVINSON B., WALTER B. A., WINTROBE M. M., CARTWRIGHT G. E. A clinical study in Hodgkin's disease. AMA Arch Intern Med. 1957 Apr;99(4):519–535. doi: 10.1001/archinte.1957.00260040019002. [DOI] [PubMed] [Google Scholar]
  11. Najean Y., Dresch C., Ardaillou N. Trouble de l'utilisation du fer hémoobinique au cours des maladies de Hodgkin évolutives. Nouv Rev Fr Hematol. 1967 Sep-Oct;7(5):739–754. [PubMed] [Google Scholar]
  12. YOUNG D. S., HICKS J. M. METHOD FOR THE AUTOMATIC DETERMINATION OF SERUM IRON. J Clin Pathol. 1965 Jan;18:98–102. doi: 10.1136/jcp.18.1.98. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES